Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Hereditary Cancer in Clinical Practice is Scopus-indexed (Q2, CiteScore 4.3), WoS SCIE, DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 1731-2302Verify ISSN ↗1897-4287Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 203 / 428 | 52nd | Q2 |
| Genetics (clinical) | 51 / 100 | 49th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2004–present, best quartile Q2, CiteScore 4.3.
Hereditary Cancer in Clinical Practice is Q2 in Oncology (rank 203 of 428) and Q3 in Genetics (clinical) (rank 51 of 100), by CiteScore 2025.
Hereditary Cancer in Clinical Practice is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.3, which places it in quartile Q2 at the 52nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.049, quartile Q2, with an H-index of 36.
The publisher lists an article processing charge of about US$2,690 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Hereditary Cancer in Clinical Practice is published by BioMed Central Ltd. Its print ISSN is 1731-2302 and its online ISSN is 1897-4287.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Hereditary Cancer in Clinical Practice has an h-index of 42 and a 2-year mean of 2.53 citations per paper (OpenAlex). Its Scopus CiteScore is 4.3, quartile Q2. On 2-year citations it ranks #146 of 424 Scopus journals in Oncology.
Hereditary Cancer in Clinical Practice published 28 papers in 2025; its busiest recent year was 2021 with 49. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2023–2026), authors are most often from United States (15.6%), Canada (10.7%) and Japan (8.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (2.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.